Compare Ginkgo Bioworks Holdings Inc (DNA) vs Illinois Tool Works Inc. (ITW) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ginkgo Bioworks Holdings Inc vs Illinois Tool Works Inc. — how do they compare? Ginkgo Bioworks Holdings Inc trades at $9.06 (market cap $590.53M), while Illinois Tool Works Inc. trades at $273.5 (market cap $78.33B). The key difference: Illinois Tool Works Inc. is far larger — about 132.6× Ginkgo Bioworks Holdings Inc's market cap, and Illinois Tool Works Inc. pays a 2.37% dividend while Ginkgo Bioworks Holdings Inc pays none. Which is the better fit depends on your goals.
| DNA | ITW | |
|---|---|---|
Market Cap | $590.53M | $78.33B |
Sector | Health | Industrials |
52-Week High | $16.14 | $299.60 |
52-Week Low | $5.48 | $241.07 |
Enterprise Value | $627.78M | $86.66B |
Dividend Yield | — | 2.37% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DNA trades at $9.05, down 0.44% on the day, reflecting ongoing investor caution. The technical outlook is bearish, while fundamentals show significant losses with a net income margin of -201.05% and negative cash flows. Recent earnings have been mixed, missing estimates in two of the last three quarters. Analyst sentiment is divided, with a slight lean toward buy ratings amid high volatility and operational challenges.
The outlook remains challenging due to persistent losses and cash burn, though analyst coverage suggests potential long-term value. Key risks include execution missteps and intense competition in biotechnology. Investment appeal hinges on future profitability improvements and successful business model execution.
Illinois Tool Works (ITW) trades at $271.50, up 1.0% today, with a bullish technical signal from moving averages and a consensus analyst price target of $288.25. The company has consistently beaten earnings estimates in recent quarters, including Q1 2026 EPS of $2.66 versus $2.57 expected, and maintains strong profitability with a net income margin of 19.32% and ROE of 96.88%. Recent news highlights segment strength and a declared quarterly dividend of $1.61.
The outlook for ITW is positive, supported by earnings momentum and operational efficiency, though risks include construction sector weakness and currency headwinds. The stock offers a balanced opportunity with solid fundamentals and a dividend, but investors should weigh high valuation multiples against growth prospects.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Ginkgo Bioworks Holdings Inc
Ginkgo Bioworks is a leading horizontal platform for cell programming. It uses advanced automation and software to design custom organisms for customers across diverse industries, including food, agriculture, and pharma.
Read more on DNA →About Illinois Tool Works Inc.
Illinois Tool Works is a diversified global manufacturer that produces specialized industrial equipment, consumables, and related services. The firm operates 87 global divisions through seven distinct operating segments: automotive OEM, construction products, food equipment, specialty products, test/measurement and electronics, polymers and fluids, and welding. About half of its revenue comes from its operations in North America, with the remainder originating from international markets. ITW takes a bottom-up and decentralized approach to portfolio management, with the exception that each segment must apply its 80/20 operating process modeled on the Pareto principle.
Read more on ITW →
